10 recruiting. 10 Phase 1, 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 10 | Recruiting 10 |
| Phase 2 | 5 | Recruiting 5 |
Follow Ischemic Stroke: new trials by email Literature Review of Ischemic Stroke trials Research Report on Ischemic Stroke
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Intra-Arterial Magnesium Therapy After Mechanical Thrombectomy in Acute Ischemic Stroke Magnesium sulfate - Acute Ischemic Stroke | Phase 1 | Recruiting | Baylor College of Medicine | 30 | 2026-07-01 | 2026-10-01 |
| Human Placenta-derived 3D Mesenchymal Stem Cells(Guojianqingke) Human Placenta-derived 3D Mesenchymal Stem Cells (Guojiangqingke) - Acute Ischemic Stroke | Phase 1 / Phase 2 | Recruiting | Chinese PLA General Hospital | 24 | 2026-06-01 | 2026-06-09 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LWP779 in Healthy Participants LWP779, Placebo of LWP779 - Ischemic Stroke | Phase 1 | Recruiting | Longwood Pharmaceuticals (Hangzhou) Co., Ltd. | 76 | 2026-03-13 | 2026-03-20 |
| Psychedelic Healing: Adjunct Therapy Harnessing Opened Malleability Psilocybin (Usona Institute) - Stroke, Chronic Stroke | Phase 1 | Recruiting | Johns Hopkins University | 20 | 2026-02-09 | 2026-02-13 |
| A Study of B2065 in Patients With Acute Ischemic Stroke B2065, Placebo - Acute Ischemic Stroke | Phase 1 / Phase 2 | Recruiting | Tasly Pharmaceutical Group Co., Ltd | 54 | 2025-12-31 | 2026-08-13 |
| The Safety and Efficacy of NouvSoma001 in Ischemic Stroke extracellular vesicles derived from human induced neural stem cell for intravenous injection, a placebo of extracellular vesicles derived from human induced neural stem cell for intravenous injection - Ischemic Stroke | Phase 1 | Recruiting | Wei Wang | 69 | 2025-11-30 | 2026-01-21 |
| Qingre Huatan Formula for the Prevention of Early Neurological Deterioration in Acute Ischemic Stroke Qingre Huatan Formula, Qingre Huatan Formula placebo, Guidelines-based standard care - Acute Ischemic Stroke | Phase 1 / Phase 2 | Recruiting | Dongzhimen Hospital, Beijing | 72 | 2025-06-13 | 2025-12-01 |
| Study on Hibernation-like Therapy Based on Mechanical Thrombectomy chlorpromazine and promethazine, Placebo group, endovascular thrombectomy - Acute Ischemic Stroke | Phase 1 | Recruiting | Capital Medical University | 32 | 2024-11-09 | 2024-12-20 |
| Safety and Efficacy of CG-BM1 in Ischemic Stroke single infusion, 1.0 × 10^6 cells/kg, single infusion, 2.0 × 10^6 cells/kg, single infusion, 3.0 × 10^6 cells/kg - Ischemic Stroke or High-risk TIA (ABCD² ≥ 4) | Phase 1 / Phase 2 | Recruiting | GuangZhou Cellgenes Biotechnology Co., Ltd. | 87 | 2024-09-30 | 2026-10-28 |
| Verapamil for Neuroprotection in Stroke 10 mg Intra-arterial Verapamil, 20 mg Intra-arterial Verapamil - Ischemic Stroke | Phase 1 / Phase 2 | Recruiting | Global Neurosciences Institute | 60 | 2017-04-20 | 2025-01-17 |
Stroke (2) · Cerebral Hemorrhage (1) · Hemiplegia (1) · Hemorrhagic Stroke (1) · Infarction, Middle Cerebral Artery (1) · Paresis (1)
Brain Diseases (10) · Cardiovascular Diseases (10) · Central Nervous System Diseases (10) · Cerebrovascular Disorders (10) · Nervous System Diseases (10) · Vascular Diseases (10) · Stroke (8) · Brain Infarction (1) · Brain Ischemia (1) · Cerebral Arterial Diseases (1) · Cerebral Infarction (1) · Hemorrhage (1) · Infarction (1) · Intracranial Arterial Diseases (1) · Intracranial Hemorrhages (1)
Chlorpromazine (1) · Control Groups (1) · Injections, Intravenous (1) · Magnesium Sulfate (1) · Promethazine (1) · Psilocybin (1)
Baylor College of Medicine (1) · Capital Medical University (1) · Chinese PLA General Hospital (1) · Dongzhimen Hospital, Beijing (1) · Global Neurosciences Institute (1) · GuangZhou Cellgenes Biotechnology Co., Ltd. (1) · Johns Hopkins University (1) · Longwood Pharmaceuticals (Hangzhou) Co., Ltd. (1) · Tasly Pharmaceutical Group Co., Ltd (1) · Wei Wang (1)
China (6) · United States (3) · Australia (1)
Chuan Qin, MD (1) · Daishi Tian, MD (1) · Omar Tanweer, MD (1) · Victor Urrutia, M.D. (1) · Wei Wang, MD (1) · Xunming Ji, Doctor (1)